Parkinson's Disease
Conference Coverage
Safety and Efficacy of Five Years of Levodopa–Carbidopa Intestinal Gel Treatment
PORTLAND, OR—Most patients with advanced Parkinson’s disease who received levodopa–carbidopa intestinal gel in an open-label, continued-access-to-...
Conference Coverage
Amantadine Hydrochloride Reduces Levodopa-Induced Dyskinesia in Patients With Parkinson’s Disease
PORTLAND, OR—Amantadine hydrochloride extended-release capsules, compared with placebo, result in a statistically significant and clinically...
Conference Coverage
Common Genetic Variants Associated With Cognitive Impairment in Parkinson’s Disease
PORTLAND, OR—A large-scale analysis has identified several new putative susceptibility genes that may affect cognitive impairment in Parkinson's...
Conference Coverage
How Do Autonomic Symptoms Affect Patients With Early Parkinson’s Disease?
PORTLAND, OR—Autonomic symptoms are present in a majority of patients with early Parkinson’s disease, and symptoms correlate with markers of...
Conference Coverage
High-Intensity Exercise May Be Feasible in Patients With Parkinson’s Disease
PORTLAND, OR—High-intensity exercise is feasible and safe in patients with Parkinson’s disease, according to trial results presented at the Fourth...
Conference Coverage
Transcranial Direct Current Stimulation Enhances Cognitive Training in Parkinson’s Disease
PORTLAND, OR—Combining transcranial direct current stimulation (tDCS) and cognitive training resulted in an improvement in a greater number of...
Conference Coverage
Does Transdermal Nicotine Benefit Patients With Parkinson’s Disease?
PORTLAND, OR—High doses of transdermal nicotine failed to improve off motor symptoms in patients with Parkinson’s disease, according to trial...
Literature Review
Statins Are Underused in Recent-Onset Parkinson’s Disease
Many patients with recent-onset Parkinson’s disease have increased cardiovascular risk, but statin therapy is underused in this population,...
Conference Coverage
Polychlorinated Biphenyls Are Associated With Risk of Parkinson’s Disease
PORTLAND, OR—Higher serum levels of polychlorinated biphenyls (PCBs) were associated with an increased risk of Parkinson’s disease in two...
Conference Coverage
Can a Diabetes Drug Treat Parkinson’s Disease?
PORTLAND, OR—Researchers have completed a double-blinded, placebo-controlled trial examining the potential benefits of a new formulation of...
Conference Coverage
Asleep Deep Brain Stimulation Placement Offers Advantages in Parkinson’s Disease
PORTLAND, OR—Performing deep brain stimulation (DBS) surgery for Parkinson’s disease using intraoperative CT imaging while the patient is under...